UbiQ Bio BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:UbiQ Bio BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013510
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polypeptides. It also offers Ub-conjugate services such as Ubiquitin conjugate service and Ubiquitin mutant service. UbiQ products also serve pharma companies and academic research labs. The company’s technology platform consists of UbiQ-Block, UbiQ-Click, and UbiQ-Syn that are used to develop products and services in the ubiquitin field. UbiQ is headquartered in Amsterdam, the Netherlands.

UbiQ Bio BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV – Key Competitors 14
UbiQ Bio BV – Key Employees 15
UbiQ Bio BV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
UbiQ Bio BV, Pharmaceuticals & Healthcare, Key Facts 2
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UbiQ Bio BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UbiQ Bio BV, Deals By Therapy Area, 2011 to YTD 2017 8
UbiQ Bio BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mercachem Forms Joint Venture with UbiQ Bio 10
Ubiquigent Enters into Co-Development Agreement with UbiQ 11
Avacta Enters Into Agreement With UbiQ Bio For Ubiquitin Affimers 12
UbiQ Partners with Neuroscience 13
UbiQ Bio BV, Key Competitors 14
UbiQ Bio BV, Key Employees 15
UbiQ Bio BV, Joint Venture 16

★海外企業調査レポート[UbiQ Bio BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Gap, Inc.:企業の戦略・SWOT・財務情報
    The Gap, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Gap, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ifa systems AG (IS8):企業の財務・戦略的SWOT分析
    ifa systems AG (IS8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Outokumpu Oyj:戦略・SWOT・企業財務分析
    Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report Summary Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Jakks Pacific, Inc.:企業の戦略・SWOT・財務分析
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • K3 Business Technology Group plc (KBT):企業の財務・戦略的SWOT分析
    Summary K3 Business Technology Group plc (K3 BTG) is an information technology company that provides integrated business systems. The company offers products including axis fashion, fresh dynamics, MS dynamics AX, MS dynamics NAV, pebblestone fashion, sage, and syspro. Its services comprise CRM, ERP …
  • BESIX Group SA:企業の戦略的SWOT分析
    BESIX Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Banque Nationale Agricole SA:企業の戦略・SWOT・財務分析
    Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report Summary Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Quest PharmaTech Inc (QPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • GVK Biosciences Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Genae Associates NV:医療機器:M&Aディール及び事業提携情報
    Summary Genae Associates NV (Genae Group) is a medical device CRO that offers clinical trial management services. The organization develops and commercializes investigational products and therapies that advance practices in medicine. Its services comprise clinical trial management, regulatory and sa …
  • IHI Corporation:企業の戦略・SWOT・財務分析
    IHI Corporation - Strategy, SWOT and Corporate Finance Report Summary IHI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company's lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platfor …
  • Lukoil Oil Co (LKOH):電力:M&Aディール及び事業提携情報
    Summary Lukoil Oil Company (Lukoil) is a vertically integrated oil and gas company, which carries out exploration and production of crude oil and natural gas. Lukoil has interest in properties across Russia, Kazakhstan, Azerbaijan, Uzbekistan, the Middle East, South America, Northern and Western Afr …
  • Hengeler Mueller Partnerschaft von Rechtsanwalten mbB:企業の戦略的SWOT分析
    Hengeler Mueller Partnerschaft von Rechtsanwalten mbB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • The Hub Power Co Ltd (HUBC):企業の財務・戦略的SWOT分析
    The Hub Power Co Ltd (HUBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆